Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

OBJECTIVES: Hydroxychloroquine is an antimalarial agent that has been used in systemic lupus erythematosus and rheumatoid arthritis treatment for many years. Recently, novel mechanisms of action have been proposed, thereby broadening the therapeutic perspective of this medication. The purpose of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Juliana Cruz, Mariz, Henrique Ataide, da Rocha Júnior, Laurindo Ferreira, Santana de Oliveira, Priscilla Stela, Dantas, Andrea Tavares, Duarte, Angela Luzia Branco Pinto, da Rocha Pitta, Ivan, Galdino, Suely Lins, da Rocha Pitta, Maira Galdino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674253/
https://www.ncbi.nlm.nih.gov/pubmed/23778483
http://dx.doi.org/10.6061/clinics/2013(06)07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674253/
https://www.ncbi.nlm.nih.gov/pubmed/23778483
http://dx.doi.org/10.6061/clinics/2013(06)07

Ejemplares similares